Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

8,823 evidence items · page 194 / 353

1.3 ratioThe DOT per LOT across cohorts was 1.3 for severe cases.

NigeriaCOVID-19HAL · Unilimdocument of 63 observations

100 %The combined stool and sputum GeneXpert testing achieved 100% sensitivity.

Nigeriatuberculosepublished 2026BMC infectious diseasesPubMeddocument of 10 observations

4.9 odds_ratioThe adjusted odds ratio for finding an HIV-positive child at the pediatric inpatient ward compared with the POPD was 4.9 (95% CI: 1.9–12.8).

NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 16 observations

45.4 %Alpha thalassemia was present at a prevalence of 45.4% in sickle cell disease patients.

Nigeriaalpha thalassemia · drépanocytosepublished 2022Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument of 17 observationsDOI 10.4084/mjhid.2022.001

100 %After PCR correction, adequate clinical and parasitological response (ACPR) was achieved in 100% of individuals treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.

Nigeriapaludismepublished 2024Malaria journalPubMeddocument of 7 observations

10.4 μg/mLHexane extracts of Ficus thonningii and Lophira alata were the most effective in vitro against Plasmodium falciparum K1 strain with IC50 of 10.4 ± 1.6 μg/mL and 2.5 ± 2.1 μg/mL, respectively.

Nigeriapaludisme · Plasmodium falciparum K1published 2014Journal of parasitology researcheurope_pmcdocument of 5 observations

91.7 %91.7% of participants reported lack of information as a barrier to COVID-19 vaccine uptake.

NigeriaCOVID-19observed April-June 2024published 2026Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 8 observations

38.1 %Among RT-PCR-negative patients, 38.1% had co-morbidity, compared to 27.8% among RT-PCR-positive patients.

NigeriaCOVID-19observed 27 February 2020 to 30 September 2020published 2021The Nigerian postgraduate medical journalPubMeddocument of 12 observations

295 suspected_casesIn the past four weeks, Nigeria registered 295 suspected mpox cases and 28 confirmed cases, with no deaths reported.

Nigeriampoxobserved past four weeksAfrica CDCdocument of 147 observations

7.63 %The overall hepatitis B positivity rate in Nigeria was 7.63%.

Nigeriahépatite Bobserved 2018published 2021Annals of global healthPubMeddocument of 12 observations

90 %The dhfr-IRNI haplotype was identified at a frequency of 90% in clinical isolates from northern Nigeria.

Nigeriapaludismepublished 2025Scientific reportsPubMeddocument of 3 observations

51.1 %In the case group, more than half (51.1%) of newly diagnosed patients with primary invasive breast cancer in Nigeria never consumed beans_alone in the past year.

Nigeriacancer du seinpublished 2022Cancer causes & control : CCCPubMeddocument of 7 observations

5 cmThe difference in tumor size between detection and arrival at a specialist clinic was 5.0 ± 4.9 cm (95% CI 4.0–5.0).

Nigeriacancer du seinobserved June 2017 to May 2018published 2020BMC public healthPubMeddocument of 9 observations

66.7 %In this study, 66.7% of the 117 youth living with HIV/AIDS in Lagos State reported fear of HIV disclosure as a barrier to service utilisation.

NigeriaVIH/sidaobserved 2022published 2025African journal of reproductive healthPubMeddocument of 7 observations

18 %The WHO region of the Western Pacific accounted for 18% of people with TB globally in 2019.

Nigeriatuberculoseobserved 2019published 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 18 observations

13.2 %In the study, 13.2% of children with sickle cell anaemia had proteinuria.

Nigeriadrépanocytosepublished 2024West African journal of medicinePubMeddocument of 9 observations

76.5 %An ROC-derived optimal cutoff of 96.6 for platelet-to-neutrophil ratio yielded a specificity of 76.5% for predicting avascular necrosis.

Nigeriaavascular necrosispublished 2025Annals of hematologyPubMeddocument of 5 observations

68.6 %Among 229 HIV-1 positive individuals, 68.6% were ART-experienced.

NigeriaVIH/sidaobserved May 2023 to August 2024published 2025AIDS research and therapyPubMeddocument of 7 observations

99 %Two sibling species of An. gambiae s.l. were confirmed: An. gambiae s.s. and An. coluzzii, with 99% of the Anopheles being An. coluzzii in all the 17 LGAs.

Nigeriapaludismepublished 2025Scientific reportsPubMeddocument of 6 observations

6,622 casesThe number of people living with HIV who initiated tuberculosis preventive treatment across all CDC-supported sites in Nigeria increased from 6622 in May 2018 to 48,661 in September 2018.

Nigeriatuberculosis preventive treatmentobserved May 2018published 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 3 observations

35.8 %The prevalence of disclosure of HIV status to children living with HIV was 35.8% in Gombe, northeast Nigeria.

NigeriaVIH/sidapublished 2020BMC public healthPubMeddocument of 5 observations

98.1 %98.1% of the 790 respondents reported a positive experience with HPV self-sampling.

Nigeriainfection à HPVpublished 2024African health sciencesPubMeddocument of 5 observations

1.17 aORAdolescents and young adults in the 'consent and proximity' class were more likely to report engaging in intergenerational sex (adjusted odds ratio 1.17, 95% confidence interval 1.02–1.35).

NigeriaVIH/sidaobserved 2018published 2024PloS onePubMeddocument of 15 observations

15 %During the 2007-2010 administration, malaria control efforts resulted in a 15% reduction in malaria cases.

Nigeriapaludismeobserved 2007-2010published 2026PloS onePubMeddocument of 6 observations

100 %The TB surveillance system had 100% timeliness.

Nigeriatuberculosepublished 2020The Pan African medical journalPubMeddocument of 5 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.